FDA Approvals - Ikonisys Receives FDA Clearance For Non-Invasive, HER-2 Breast Cancer Test
Ikonisys Receives FDA Clearance For Non-Invasive, HER-2 Breast Cancer Test (Medical News Today)
Ikonisys, a leading provider of next generation, non-invasive, cell-based diagnostic solutions, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its oncoFISH her2 test.
FDA Statement On Release Of Bisphenol A (BPA) Subcommittee Report (Medical News Today)
We appreciate the hard work and long hours the subcommittee has invested in scientific peer review of the FDA's draft safety assessment of the use of BPA in food contact applications. The FDA requested this peer review to provide additional insight into this complex issue. This group of distinguished scientists has devoted their considerable knowledge and experience to this effort.